AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial

S Krabbe; M Østergaard; I J Sørensen; B Jensen; O R Madsen; G P Eng; K H Asmussen; J Møller; L Balding; S J Pedersen

doi:10.1136/annrheumdis-2016-eular.1393

AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial

S Krabbe, M Østergaard, I J Sørensen, B Jensen, O R Madsen, G P Eng, K H Asmussen, J Møller, L Balding, S J Pedersen

Department of Clinical Medicine

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	Suppl 2
Pages (from-to)	1131-1132
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2016-eular.1393
Publication status	Published - 2016

Access to Document

10.1136/annrheumdis-2016-eular.1393

Cite this

Krabbe, S., Østergaard, M., Sørensen, I. J., Jensen, B., Madsen, O. R., Eng, G. P., Asmussen, K. H., Møller, J., Balding, L., & Pedersen, S. J. (2016). AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases, 75(Suppl 2), 1131-1132. https://doi.org/10.1136/annrheumdis-2016-eular.1393

AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial. / Krabbe, S; Østergaard, M; Sørensen, I J et al.

In: Annals of the Rheumatic Diseases, Vol. 75, No. Suppl 2, 2016, p. 1131-1132.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Krabbe, S, Østergaard, M, Sørensen, IJ, Jensen, B, Madsen, OR, Eng, GP, Asmussen, KH, Møller, J, Balding, L & Pedersen, SJ 2016, 'AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial', Annals of the Rheumatic Diseases, vol. 75, no. Suppl 2, pp. 1131-1132. https://doi.org/10.1136/annrheumdis-2016-eular.1393

@article{6f9fe8132030453d8f1bfd16e5b32d8c,

title = "AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial",

author = "S Krabbe and M {\O}stergaard and S{\o}rensen, {I J} and B Jensen and Madsen, {O R} and Eng, {G P} and Asmussen, {K H} and J M{\o}ller and L Balding and Pedersen, {S J}",

year = "2016",

doi = "10.1136/annrheumdis-2016-eular.1393",

language = "English",

volume = "75",

pages = "1131--1132",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - AB0663 Efficacy and Safety of Adalimumab in Patients with Axial Spondyloarthritis - An Investigator-Initiated Randomized Placebo-Controlled Trial

AU - Krabbe, S

AU - Østergaard, M

AU - Sørensen, I J

AU - Jensen, B

AU - Madsen, O R

AU - Eng, G P

AU - Asmussen, K H

AU - Møller, J

AU - Balding, L

AU - Pedersen, S J

PY - 2016

Y1 - 2016

U2 - 10.1136/annrheumdis-2016-eular.1393

DO - 10.1136/annrheumdis-2016-eular.1393

M3 - Conference abstract in journal

SN - 0003-4967

VL - 75

SP - 1131

EP - 1132

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -